iPharma Tirzepatide 30mg Self-Mix Vial
Tirzepatide in a self-mix vial, studied for weight loss and blood-sugar control.
Description
iPharma Tirzepatide (a dual GIP/GLP-1 receptor agonist) supplied as a 30mg self-mix vial, researched for appetite regulation, weight management and blood-sugar control.